Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
GWR7U9ubvKqYtcPj